Senior Oncology Clinical Ops & Strategy Lead (Hybrid)

GlaxoSmithKline

Durham (NC)

Hybrid

USD 120,000 - 180,000

Full time

4 days ago
Be an early applicant
Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Benefits offered by this job

Hybrid work model
Competitive benefits

Job summary

GlaxoSmithKline is seeking a senior professional to lead operational delivery for late-phase oncology assets. You will work with EDT/MDT, Study Team and COAL to keep studies inspection-ready and deliver regulatory-grade data.

The role emphasizes clear decision making, collaborative leadership, and practical problem solving with growth opportunities across regulatory and program strategy. Hybrid work with onsite days.

Qualifications

  • Bachelor's degree in life sciences or equivalent required.
  • Experience in oncology clinical development.
  • Experience in vendor management and oversight of CRO relationships.
  • Experience applying GCP and clinical development processes.

Responsibilities

  • Lead and deliver operational strategy for late-phase oncology assets.
  • Coordinate cross-functional inputs to meet timelines and quality expectations.
  • Represent DevOps at EDT/MDT and support budget forecasting.

Skills

Analytical Thinking
Clinical Data Interpretation
Clinical Data Review
Clinical Development
Clinical Trial Designs
Clinical Trials Monitoring
Cross-Departmental Collaboration
Digital Fluency
Drug Regulatory Affairs
Executive Presence
Hematology and Oncology
Learning Agility
Matrix Leadership
Scientific Presentations

Education

Bachelor's degree in life sciences

Job description

GlaxoSmithKline is seeking a senior professional to lead operational delivery for late-phase oncology assets. You will work with EDT/MDT, Study Team and COAL to keep studies inspection-ready and deliver regulatory-grade data.

The role emphasizes clear decision making, collaborative leadership, and practical problem solving with growth opportunities across regulatory and program strategy. Hybrid work with onsite days.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Oncology Operations Lead – Late-Phase Programs
Senior Oncology Operations Lead – Late-Phase Programs

GlaxoSmithKline • Upper Providence

Hybrid
USD 140,000 - 190,000
Hybrid work model
Global Oncology Medical Director — Hybrid Evidence & Strategy
Global Oncology Medical Director — Hybrid Evidence & Strategy

GlaxoSmithKline • Philadelphia

Hybrid
USD 198,000 - 330,000
Annual bonus
Long-term incentive
Health benefits
+3
Hybrid Senior Clinical Development Project Manager
Hybrid Senior Clinical Development Project Manager

GlaxoSmithKline • Waltham (MA)

Hybrid
USD 139,000 - 232,000
Oncology Clinical Operations Lead: Asset Strategy
Oncology Clinical Operations Lead: Asset Strategy

GlaxoSmithKline • Upper Providence

Hybrid
USD 150,000 - 210,000
Senior Medical Director, Oncology Safety & PV Lead
Senior Medical Director, Oncology Safety & PV Lead

GlaxoSmithKline • United States

Hybrid
USD 285,000 - 474,000
Annual bonus
Long-term incentive program
Health care
+1
Hybrid Medical Director, Oncology Clinical Development
Hybrid Medical Director, Oncology Clinical Development

GlaxoSmithKline • Waltham (MA)

Hybrid
USD 230,000 - 350,000
Senior Clinical Development Project Manager - Oncology (Hybrid)
Senior Clinical Development Project Manager - Oncology (Hybrid)

Oncology Voice Network LLC • Northern (KY)

Hybrid
USD 139,000 - 232,000
Health insurance
Retirement benefits
Paid holidays
+3
Senior Oncology Clinical Development Director (Hybrid)
Senior Oncology Clinical Development Director (Hybrid)

Merck • Boston (MA)

Hybrid
USD 311,000 - 489,000
Senior Medical Director — Oncology Clinical Development
Senior Medical Director — Oncology Clinical Development

GlaxoSmithKline • Upper Providence

Hybrid
USD 257,000 - 355,000
Oncology Market Access Strategy Lead
Oncology Market Access Strategy Lead

GlaxoSmithKline • United States

Hybrid
USD 180,000 - 260,000